Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/01/1998US5843636 Hepatitis C virus epitopes
12/01/1998US5843462 Diphtheria toxin epitopes
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843453 Growth hormone potentiating molecules
12/01/1998US5843452 Immunotherapy composition and method
12/01/1998US5843450 Hepatitis GB Virus synthetic peptides and uses thereof
12/01/1998US5843449 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
12/01/1998US5843448 Tumor rejection antigen precursor
12/01/1998US5843445 Method of treating rheumatoid arthritis with type II collagen
12/01/1998US5843442 Blood coagulation protein antagonists and uses therefor
12/01/1998US5843441 Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
12/01/1998US5843440 Cellular and serum protein anchors for modulating pharmacokinetics
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843437 A82846 antibiotics
12/01/1998US5843436 Method of preventing and treating bacterial infection of sutures and prosthetic devices, and promoting ingress of leukocytes into tumor foci
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
12/01/1998US5843432 Retroviral vectors for the treatment of tumors, and cell lines containing them
12/01/1998US5843430 Methods of treating disease using sertoli cells and allografts or xenografts
12/01/1998US5843425 Transplantation and graft-versus-host-disease
12/01/1998US5843423 Methods of stimulating hematopoietic cells with flt3-ligand
12/01/1998US5843422 Method and compositions for treating injury
12/01/1998US5843405 Epstein-Barr virus peptides and antibodies against these peptides
12/01/1998US5843401 Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
12/01/1998US5843398 Radioimmunotherapy of lymphoma using anti-CD20 antibodies
12/01/1998US5843114 Skin perforating apparatus for transdermal medication
12/01/1998US5843089 Stent lining
12/01/1998CA2104381C Production and use of butyrylcholinesterase
12/01/1998CA2022429C Methods and compositions for ameliorating the symptoms of sepsis
11/1998
11/30/1998CA2239140A1 The use of polymers for inhibiting the denaturation of adsorbed proteins
11/30/1998CA2233580A1 Histidine kinase
11/30/1998CA2233577A1 Histidine kinase
11/30/1998CA2233572A1 Histidine kinase
11/30/1998CA2233554A1 Novel compounds
11/30/1998CA2233547A1 Histidine kinase
11/30/1998CA2233539A1 Histidine kinase
11/29/1998CA2233565A1 Novel compounds
11/29/1998CA2233561A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/27/1998CA2232817A1 Novel compounds
11/27/1998CA2232814A1 Novel compounds
11/26/1998WO1998053102A1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053101A2 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053082A1 A recombinant microorganism expressing an antigenic protein, adhesin
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/26/1998WO1998053071A1 Modulators of tissue regeneration
11/26/1998WO1998053070A1 Human gp12 homolog
11/26/1998WO1998053069A2 Gdnf receptors
11/26/1998WO1998053068A1 Smad7 and uses thereof
11/26/1998WO1998053066A1 Smad2 phosphorylation and interaction with smad4
11/26/1998WO1998053065A1 Human semaphorin e and polynucleotides encoding it
11/26/1998WO1998053063A2 Mammalian cell transduction for use in gene therapy
11/26/1998WO1998053061A1 Three novel genes encoding a zinc finger protein, a guanine, nucleotide exchange factor and a heat shock protein or heat shock binding protein
11/26/1998WO1998053059A1 Nucleic acid binding proteins
11/26/1998WO1998053054A1 Dna encoding canine interleukin-1 receptor antagonist
11/26/1998WO1998053051A1 Short peptides which selectively modulate intracellular signalling
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998053048A1 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
11/26/1998WO1998052976A1 Method for the production of non-immunogenic proteins
11/26/1998WO1998052973A1 New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
11/26/1998WO1998052972A1 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents
11/26/1998WO1998052971A1 DIROFILARIA AND $I(BRUGIA) THIOREDOXIN PEROXIDASE TYPE-2 (TPx-2) PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
11/26/1998WO1998052970A1 Vif-derived hiv protease inhibitors
11/26/1998WO1998052967A1 New echinocandide derivatives with antimicrobial activity
11/26/1998WO1998052966A1 Tissue specific prodrug
11/26/1998WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998WO1998052958A1 Human uncoupling protein 3
11/26/1998WO1998052614A2 Composition and method for enhancing transport across biological membranes
11/26/1998WO1998052607A1 88kda tumorigenic growth factor and antagonists
11/26/1998WO1998052606A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998WO1998052602A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/26/1998WO1998052601A1 Cleavage of fibrin(ogen) and cross-linked fibrin by fibrinolytic matrix metalloproteinases
11/26/1998WO1998052600A1 Methods of enhancing functioning of the upper gastrointestinal tract
11/26/1998WO1998052599A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/26/1998WO1998052598A1 Novel administration of thrombopoietin
11/26/1998WO1998052597A1 Apoptosis-inducing gelsolin sequences
11/26/1998WO1998052596A1 Glycopeptide hexapeptides
11/26/1998WO1998052594A1 Compositions for enhancing immunosuppressants' pharmaceutical activities
11/26/1998WO1998052593A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998WO1998052592A1 Urea and thiourea derivatives of glycopeptides
11/26/1998WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998WO1998052590A2 Improved delivery of disease modifiers
11/26/1998WO1998052589A1 Alkylated hexapeptides
11/26/1998WO1998052586A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
11/26/1998WO1998052585A1 Immunomodulating, bile-derivable compositions for the treatment of viral disorders
11/26/1998WO1998052584A1 A method to increase the survival of transplanted cells
11/26/1998WO1998052583A1 Natural composition for treating bone or joint inflammation
11/26/1998WO1998052415A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998WO1998042746A3 Synthetic saposin c-derived neurotrophic peptides
11/26/1998WO1998041539A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998039448A3 186 human secreted proteins
11/26/1998WO1998035554A3 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/26/1998WO1998031818A3 Tace-like and matrilysin-like polypeptides
11/26/1998WO1998031800A3 Human proteins
11/26/1998WO1998030582A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998022494A3 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
11/26/1998WO1998021323A3 Reversal of drug resistance through oligonucleotide complementary to plasmodium falciparum specific region
11/26/1998DE19806186A1 New genomic and cDNA sequences encoding human mu-opioid receptor
11/26/1998CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
1 ... 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 ... 3163